STK33 and cancer: Furthermore, ectopic STK33 also partially rescued VEGF promoter activity (Figure 6C) as well as VEGF secretion (Figure 6D and Supplementary Figure 4A) in hypoxic cancer cells subjected to HSP90 inhibition.